FDA — authorised 26 May 2006
- Application: NDA050805
- Marketing authorisation holder: GALDERMA LABS LP
- Status: supplemented
FDA authorised Oracea on 26 May 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 26 May 2006; FDA has authorised it.
GALDERMA LABS LP holds the US marketing authorisation.